Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Top-Down Infliximab Study in Kids with Crohn's Disease (TISKids)
2014-005702-37Phase 4Completed
- Sponsor
- Erasmus MC
- Start
- Feb 2015
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of infliximab in Crohn's disease, sponsored by Erasmus MC. Started Feb 2015; status: completed.
02
Drugs
infliximab
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on 2014-005702-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005702-37.